Liquid biopsy for the management of NSCLC patients under osimertinib treatment

IF 6.6 2区医学 Q1 MEDICAL LABORATORY TECHNOLOGY

Critical reviews in clinical laboratory sciences Pub Date : 2024-02-02 DOI:10.1080/10408363.2024.2302116

Aliki Ntzifa, Theodoros Marras, Vasilis Georgoulias, Evi Lianidou

引用次数: 0

Abstract

Therapeutic management of NSCLC patients is quite challenging as they are mainly diagnosed at a late stage of disease, and they present a high heterogeneous molecular profile. Osimertinib changed t...

查看原文本刊更多论文

液体活检用于管理接受奥希替尼治疗的 NSCLC 患者

由于NSCLC患者主要在疾病晚期才被确诊，而且他们的分子谱具有高度异质性，因此NSCLC患者的治疗管理相当具有挑战性。奥希替尼改变了NSCLC患者的...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Critical reviews in clinical laboratory sciences 医学-医学实验技术

CiteScore

20.00

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Critical Reviews in Clinical Laboratory Sciences publishes comprehensive and high quality review articles in all areas of clinical laboratory science, including clinical biochemistry, hematology, microbiology, pathology, transfusion medicine, genetics, immunology and molecular diagnostics. The reviews critically evaluate the status of current issues in the selected areas, with a focus on clinical laboratory diagnostics and latest advances. The adjective “critical” implies a balanced synthesis of results and conclusions that are frequently contradictory and controversial.